USPTO serial 86975911
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christie Baty Hudgins
Christie Baty Hudgins Finnegan, Henderson, Farabow, Garrett & Dunner, LL901 New York Avenue, NWWashington, DC 20001UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Nasal drug delivery devices for the nasal delivery of drugs or medications in liquid form and parts and fittings for the same; manually-actuated nasal drug delivery devices for the nasal delivery of drugs or medications in liquid form by manual actuation of the delivery devices independently of an exhalation breath and parts and fittings for the same; nasal drug delivery devices for the nasal delivery of drugs or medications in liquid form using a gas flow separate to an exhalation breath and parts and fittings for the same; oral drug delivery devices for the oral delivery of drugs or medications in liquid form and parts and fittings for the same; manually-actuated oral drug delivery devices for the oral delivery of drugs or medications in liquid form by manual actuation of the delivery devices independently of an exhalation breath and parts and fittings for the same; oral drug delivery devices for the oral delivery of drugs or medications in liquid form using a gas flow separate to an exhalation breath and parts and fittings for the same; nasal drug delivery devices for the nasal delivery of drugs or medications in powder form and parts and fittings for the same; manually-actuated nasal drug delivery devices for the nasal delivery of drugs or medications in powder form by manual actuation of the delivery devices independently of an exhalation breath and parts and fittings for the same; nasal drug delivery devices for the nasal delivery of drugs or medications in powder form using a gas flow separate to an exhalation breath and parts and fittings for the same; oral drug delivery devices for the oral delivery of drugs or medications in powder form and parts and fittings for the same; manually-actuated oral drug delivery devices for the oral delivery of drugs or medications in powder form by manual actuation of the delivery device independently of an exhalation breath and parts and fittings for the same; oral drug delivery devices for the oral delivery of drugs or medications in powder form using a gas flow separate to an exhalation breath and parts and fittings for the same; nasal drug delivery nebulizers for the nasal delivery of drugs or medications and parts and fittings for the same; manually-actuated nasal drug delivery nebulizers for the nasal delivery of drugs or medications by manual actuation of the delivery nebulizers independently of an exhalation breath and parts and fittings for the same; nasal drug delivery nebulizers for the nasal delivery of drugs or medications using a gas flow separate to an exhalation breath and parts and fittings for the same; oral drug delivery nebulizers for the oral delivery of drugs or medications and parts and fittings for the same; manually-actuated oral drug delivery nebulizers for the oral delivery of drugs or medications by manual actuation of the delivery nebulizers independently of an exhalation breath and parts and fittings for the same; oral drug delivery nebulizers for the oral delivery of drugs or medications using a gas flow separate to an exhalation breath and parts and fittings for the same; nasal spray pump delivery devices for the nasal delivery of drugs or medications and parts and fittings for the same; manually-actuated nasal spray pump delivery devices for the nasal delivery of drugs or medications by manual actuation of the spray pump delivery devices independently of an exhalation breath and parts and fittings for the same; nasal spray pump delivery devices for the nasal delivery of drugs or medications using a gas flow separate to an exhalation breath and parts and fittings for the same; oral spray pump delivery devices for the oral delivery of drugs or medications and parts and fittings for the same; manually-actuated oral spray pump delivery devices for the oral delivery of drugs or medications by manual actuation of the spray pump delivery devices independently of an exhalation breath and parts and fittings for the same; oral spray pump delivery devices for the oral delivery of drugs or medications using a gas flow separate to an exhalation breath and parts and fittings for the same; intranasal drug delivery devices for the nasal delivery of drugs or medications and parts and fittings for the same; and intranasal drug delivery devices for the nasal delivery of drugs or medications using a gas flow separate to an exhalation breath and parts and fittings for the same | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 10, 2021 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Apr 14, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 25, 2019 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jan 12, 2018 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 12, 2018 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 16, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 16, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 14, 2015 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Mar 9, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 2, 2015 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Feb 9, 2015 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Feb 9, 2015 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Jan 30, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 28, 2015 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jan 28, 2015 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jan 27, 2015 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 20, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 20, 2015 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 20, 2015 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jul 17, 2014 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 17, 2014 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 17, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 26, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 26, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 21, 2014 | ALIE | ASSIGNED TO LIE | — |
| Jun 11, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 4, 2014 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| Apr 4, 2014 | LOPT | LETTER OF PROTEST EVIDENCE FORWARDED | — |
| Dec 11, 2013 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 11, 2013 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 11, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 28, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 24, 2013 | NWAP | NEW APPLICATION ENTERED | — |